Signal
WATCH → HOLD
Conviction●●●●○4 of 5
Research target$680.47Snapshot target
Thesis statusSTRENGTHENEDLast reviewed 7/11/26
Market cap$195.86BSnapshot value
Research history
See all TMO changes ↗What changed
Last reviewed
7/8/26 → 7/11/26
Conviction
1 → 4
Target
— → $680.47
Thesis status
NEEDS_MORE_DATA → STRENGTHENED
Last reviewed
Not reviewed → 7/8/26
Life-science tools oligopoly: razor-blade consumable pull across the entire biopharma R&D stack. Paid per experiment regardless of which drug wins.
AI-bundled autonomous instruments (NVIDIA partnership DGX Spark / NeMo agentic workflows, 2H 2026); consolidation tailwind (Solventum purification/filtration $4.1B acquisition); recurring reagent revenue ~75% of proteomics market.
Research funding collapse (NIH indirect-cost cap, flat academic budgets); AI-coupling shifts factor-load toward AI trade; China softness; integration risk from M&A wave.
needs X/Reddit sentiment sweep
Snapshot · 7/11/26🟢 Lean-Bull · ins-$3.0M · 13F 16+/9- · short↑0.24
Snapshot · 7/11/26